SWOT Analysis for Sarda Proteins Ltd.

Companies with no Debt
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
PEG lower than Industry PEG
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
New 52 Week High
Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining profits every quarter for the past 2 quarters
Declining Net Cash Flow : Companies not able to generate net cash
Major fall in TTM Net Profit
Fall in Quarterly Revenue and Net Profit (YoY)
Profit to Loss Companies
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV